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cultures from a 50-year-old Chinese
woman, who had myelodysplastic
syndrome and was hospitalized for
pneumonia. She had been previously
treated with chemotherapy and had
multiple admissions for infection. The
same phenotypic and karyotypic
methods as the first patient were used
to identify the isolate. The API 20C
AUX profile was 2152134 at 48 hours
(98.5% certainty for C. dubliniensis).
The MIC of fluconazole by E-test was
also 0.75 µg/mL. Pancytopenia devel-
oped, and the patient’s condition dete-
riorated. She died of pneumonia
despite transfusions and treatment
with broad-spectrum antibiotics and
amphotericin B. Microbiologic inves-
tigations for bacteria, tuberculosis,
pneumocystis, Legionella, and viruses
did not yield positive results except
for  Corynebacterium species in the
bronchial alveolar lavage fluid. 
Although C. dubliniensis was first
associated with oral candidiasis in
HIV-infected persons (3), several
reports now link the organism to non-
HIV patients who were immunosup-
pressed due to chemotherapy, hemato-
logic malignancy (4), and end-stage
liver disease (1). Our two patients
were not HIV positive but were immu-
nosuppressed. In vitro susceptibility
results showed that our patients should
have responded to the usual antifungal
treatment. However, they died despite
appropriate therapy.
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Cases of Diarrhea in 
São Paulo, Brazil
To the Editor: Shiga toxin-pro-
ducing  Escherichia coli (STEC)
strains are associated with a spectrum
of diseases ranging from mild to
severe bloody diarrhea and complica-
tions such as hemolytic uremic syn-
drome (HUS) and thrombotic
thrombocytopenic purpura (1). Since
STEC was linked with hemorrhagic
colitis in 1982 (2), strains—particu-
larly serotype O157:H7—have been
associated with numerous outbreaks
and many sporadic cases of infections
worldwide. STEC is now a major
cause of foodborne disease, primarily
in the United States, Canada, Japan,
and Europe (1,3). Although most spo-
radic cases and outbreaks have been
reported from developed countries,
human infections associated with
STEC strains have also been described
in Latin American countries, including
Argentina and Chile (3). In Brazil,
STEC infections have been related to
sporadic cases of nonbloody diarrhea
caused by non-O157 strains (4,5);
serotype O157:H7 has not been previ-
ously isolated from human infections
in our country.
We report the characterization of
three O157:H7 strains isolated in São
Paulo State, Brazil. The first strain
was identified among a laboratory col-
lection of 2,573 E. coli strains that
were retrospectively analyzed and iso-
lated from patients with diarrhea in
São Paulo State, from 1976 through
1999, at the Central Laboratory of
Instituto Adolfo Lutz (IAL). This
strain was isolated in 1990 from an
18-year-old patient with diarrheal dis-
ease who had AIDS. The two other
O157 strains were recently isolated
from a 4-year-old girl with bloody
diarrhea and from an adult with severe
diarrhea. Both patients were admitted
to the same hospital at Campinas, São
Paulo State, in June and July 2001,
respectively. The strains, isolated by
routine diagnostic procedures on Mac-
Conkey agar plates, were presump-
tively identified as E. coli O157 by
standard methods with specific O157
antiserum. These last two strains were
confirmed as sorbitol-negative E. coli
O157 at the IAL Regional Laboratory
at Campinas and were sent to the IAL
Central Laboratory for further charac-
terization. 
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The three O157 E. coli strains
underwent biochemical identification
and serotyping by standard methods.
Enterohemolysin production was
determined according to Beutin et al.
(5). Polymerase chain reaction assays
were used to detect the stx1 and stx2
genes (6), and colony hybridization
assays with specific DNA probes for
stx1 , stx2 and  eae genes were per-
formed as described (7). Cytotoxicity
to Vero cells was assayed as described
(4). The strains were characterized as
sorbitol-negative O157:H7, containing
the  stx2 and eae sequences. The
enterohemolytic phenotype and pro-
duction of Stx were also observed in
all isolates.
To our knowledge, these O157:H7
STEC strains are the first to be associ-
ated with human diseases in Brazil.
Cultivation of stool specimens in sorb-
itol MacConkey agar is strongly rec-
ommended for screening O157 strains,
and, indeed, all three strains were iso-
lated from MacConkey agar plates.
Laboratories should attempt to exam-
ine stool specimens from all patients
(children and adults) with HUS,
severe diarrhea (nonbloody and
bloody stools) requiring hospitaliza-
tion, or both, as well as from patients
reporting a history of bloody diarrhea.
Despite the importance of
O157:H7 serotype in causing life-
threatening complications such as
HUS and the isolation of this serotype
from clinical specimens in São Paulo
State, the relatively low prevalence of
this serotype in healthy dairy and beef
cattle in Brazil (8), as well as the
occurrence of other non-O157 STEC
strains associated with human infec-
tions (4,5,9), suggest that E. coli
O157:H7 may be not as frequent as
non-O157 STEC strains in our country.
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Updates in Wilderness and Extreme Medicine
Adam's Mark Hotel
Denver, Colorado
November 9-10, 2002 
The course will provide updated approaches to prevention and treatment of
health issues relating to wilderness travel. Speakers are internationally recog-
nized authorities on wilderness medicine. The course will immediately precede,
and occur in the same venue as, the ASTMH 51st annual meeting. Category I
CME credit available for approximately 9 hours.
For additional information, contact ASTMH by telephone: 847-480-9592; e-
mail: astmh@astmh.org; or web site:http://www.astmh.org




Highlights include sessions on DNA vaccines, molecular parasitology,
pathogenesis of malaria, cytokines and parasite antigens, epidemiology of tropi-
cal diseases and mucosal immunity. The society has issued a call for papers with
a deadline of June 1, 2002, for online abstract submissions at http://abstract.cor-
netser.com/. Category I CME credit available for 30 hours.
For additional information, contact ASTMH by telephone: 847-480-9592; e-
mail: astmh@astmh.org; or web site: http://www.astmh.org 